2024. THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE. International conference on multidisciplinary science. 2, 10 (Oct. 2024), 79.